New evidence extending the benefit of treating LDL-C beyond the current guidelines
- PMID: 20425262
- DOI: 10.1007/s11883-009-0081-z
New evidence extending the benefit of treating LDL-C beyond the current guidelines
Comment on
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9. N Engl J Med. 2008. PMID: 18997196 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources